Physician
Summit Medical Group, INC.
Summit Medical Group, INC. was paid $4.74M by Medicaid between Oct 2021 and Dec 2024, across 21 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 36% of everything it billed.
33Billing provider infoSUMMIT MEDICAL GROUP, INC.
HIGHLAND HEIGHTS, KY 41076
HIGHLAND HEIGHTS, KY 41076
33aNPI1881026169assigned 08/08/2013
33bProvider typeFamily Medicine Physician
28Total paid$4.74M
24GClaims142,999
24DCodes billed21
24AFirst – last monthOct 2021 – Dec 2024
Compared with peers
Next to other Family Medicine Physician providers in Kentucky
Rank by total paid#15 of 352
Median peer was paid$90K
This provider vs. median53×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 4,792 | $137K | |
| 2022 | 43,159 | $1.31M | |
| 2023 | 49,020 | $1.71M | |
| 2024incomplete | 46,028 | $1.58M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 36% | 47,114 | 44,150 | $1.70M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 27% | 23,014 | 21,538 | $1.26M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 11% | 11,842 | 11,215 | $520K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 11% | 16,449 | 15,608 | $505K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 7.5% | 24,761 | 11,764 | $355K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3.4% | 11,405 | 10,776 | $161K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.3% | 4,198 | 4,015 | $111K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 718 | 665 | $43K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 384 | 348 | $42K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 738 | 607 | $10K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 105 | 90 | $9K |
| 87400 | <1% | 541 | 249 | $6K |
9 more codes
| 71046 | Radiologic examination, chest; 2 views | <1% | 435 | $5K |
| 87807 | <1% | 370 | $4K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 766 | $685.45 |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 37 | $538.34 |
| 84703 | <1% | 29 | $196.86 | |
| 93000 | <1% | 14 | $195.53 | |
| 73630 | <1% | 13 | $148.43 | |
| 81025 | <1% | 15 | $109.26 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 51 | $60.41 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRANKIN, MARIA (AVP - REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Summit Medical Group, INC | Erlanger, KY | $94.78M |
| Summit Medical Group, INC | Covington, KY | $4.23M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.